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Reactive oxygen species detection
A B S T R A C T
Photodynamic inactivation (PDI) or antibacterial photodynamic therapy (aPDT) is a method based on the use of
a photosensitizer, light of a proper wavelength and oxygen, which combined together leads to an oxidative stress
and killing of target cells. PDI can be applied towards various pathogenic bacteria independently on their an-
tibiotic resistance profile. Optimization of photodynamic treatment to eradicate the widest range of human
pathogens remains challenging despite the availability of numerous photosensitizing compounds. Therefore, a
search for molecules that could act as adjuvants potentiating antibacterial photoinactivation is of high scientific
and clinical importance. Here we propose farnesol (FRN), a well described sesquiterpene, as a potent adjuvant of
PDI, which specifically sensitizes Staphylococcus aureus to 5,10,15,20-tetrakis(1-methylpyridinium-4-yl)por-
phyrin tetratosylate (TMPyP) upon red light irradiation. Interestingly, the observed potentiation strongly de-
pends on the presence of light. Analysis of this combined action of FRN and TMPyP, however, showed no
influence of farnesol on TMPyP photochemical properties, i.e. the amount of reactive oxygen species that were
produced by TMPyP in the presence of FRN. The accumulation rate of TMPyP in Staphylococcus aureus cells did
not change, as well as the influence of staphyloxanthin inhibition. The precise mechanism of observed sensiti-
zation is unclear and probably involves specific molecular targets.
1. Introduction
One of the greatest challenges in global epidemiology is to combat
pathogens that escape conventional antibiotic treatment. Among them,
Staphylococcus aureus is known to cause a wide spectrum of diseases,
from mild skin infections to life-threatening systemic disorders [1]. In
contrast to the expansion of antibiotic resistance, the number of new
classes of antimicrobial drugs has been limited in recent years. One of
the approaches that can be used to fight multiresistant microorganisms
is photodynamic inactivation (PDI). PDI utilizes the combined action of
three elements: a photosensitizing compound (photosensitizer, PS),
visible light at a proper wavelength and molecular oxygen. Two types of
photodynamic reactions occur in the cell and result in oxidative stress;
type I leads to the generation of oxygen radicals, and type II results in
singlet oxygen formation. The bacteria studied thus far have not de-
veloped specific resistance to this type of oxidative stress. On the other
hand, the efficacy of PDI is often heterogeneous, and the pleiotropic
effect induced in bacterial cells is still not fully understood.
A variety of photosensitizers of different chemical structures and
properties are available for research, including porphyrins and their
cationic derivatives, phenothiazines, metal phthalocyanines and many
more [2]. In recent years, several approaches have been applied to
increase the efficacy and specificity of antimicrobial PDI. Apart from
synthetizing new PSs of desired properties, existing compounds can be
functionalized with specific antibodies [3,4] or antimicrobial peptides
[5,6]. Higher effectiveness can be achieved when the photosensitizing
compound is delivered via a bacteriophage [7] or encapsulated in lipid
nanoparticles [8]. The use of exogenous small particles or certain
compounds can also be beneficial for PDI outcome, as reported in the
case of chitosan [9], silver nanoparticles [10] and antimicrobial pep-
tides [11], as well as observed when PDI was combined with some
antibiotics [12,13]. Moreover, various materials can serve as a support
for PS immobilization, thus extending their possible use [14].
Farnesol (FRN), an acyclic sesquiterpene alcohol of natural origin,
has different applications in various industries, including perfumery,
food industry and pesticide production. Originally isolated from aro-
matic plants, farnesol is produced by many organisms, including hu-
mans. Farnesyl pyrophosphate is a key intermediate in the mevalonate/
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cholesterol pathway and is also used as a substrate for protein iso-
prenylation [15]. Due to its involvement in numerous metabolic pro-
cesses, its anticancer properties have been extensively examined. Var-
ious mechanisms of action were described using HeLa S3K cells [16],
MCF-7 human breast cancer cells [17] and blasts from patients with
acute myeloid leukemia [18]. Farnesol is also produced by the fungus
Candida albicans as a quorum-sensing molecule that prevents biofilm
formation [19]. In this context, farnesol has been examined as an an-
timicrobial agent, mainly against gram-positive human pathogens. With
respect to the inhibition of the growth and permeabilization of bacterial
membranes, FRN has been proposed as an adjuvant in antibiotic
therapy [20–22].
Here, we present the first report of using FRN to boost PDI against S.
aureus. The specific combined action of farnesol and the cationic por-
phyrin - 5,10,15,20-tetrakis(1-methylpyridinium-4-yl)porphyrin tetra-
tosylate (TMPyP) occurred upon irradiation. TMPyP is a cationic meso-
substituted porphyrin, described in the literature as a potent PS with
high singlet oxygen yield [23] and as a DNA intercalator and inhibitor
of human telomerase with potential anticancer application [24,25]. We
hypothesize that farnesol acts as an adjuvant that sensitizes S. aureus to
red light-activated TMPyP, which is ineffective for bacterial killing
when applied alone [26]. The observed phenomenon is very promising
from the perspective of potential in vivo use, not only because both
compounds have been extensively examined in eukaryotic cells but also
in view of red light application, which has beneficial therapeutic uses.
We examined the influence of farnesol on the photodynamic properties
of TMPyP, including spectral features, reactive oxygen species genera-
tion and PS accumulation in bacteria, and evaluated selected metabolic
alterations induced by FRN in S. aureus, which may contribute to
photoinactivation outcome. The exact mechanism of this combined
bactericidal action remains elusive, yet this research provides a new
perspective in the search for adjuvants for antibacterial PDI.
2. Materials and Methods
2.1. Bacterial Strains, Culture Conditions and Chemicals
The S. aureus strains used in the study included RN6390 (a non-
pigmented derivative of the 8325–4 strain containing an incomplete
rsbU gene) [27] and SH1000 (a pigmented derivative of the 8325–4
strain containing a complete rsbU gene) [28]. Bacterial cultures were
grown aerobically in a nutrient trypticase soy broth TSB (bioMèrieux,
France) at 37 °C with shaking (150 rpm), with or without farnesol. All
chemicals were purchased from Sigma-Aldrich (Germany). 1 to 10 mM
stock solutions of trans-trans-farnesol (FRN, 96% purity) were prepared
in ethanol and stored at 4 °C in the dark. 1 mM stock solutions of
TMPyP (97% purity) and toluidine blue O were prepared in sterile
double distilled water and stored at −20 °C in the dark. 1 mM stock
solution of protoporphyrin IX (≥95%) and 20 μM stock solution of zinc
phthalocyanine (97%) were prepared in DMSO and stored at −20 °C in
the dark. 2 mM stock solution of 1,6-diphenyl-1,3,5-hexatriane (DPH,
98% purity) was prepared in tetrahydrofuran (Merck, Germany), and
4 μM working solution was prepared by adding 100 μl to 50 ml of
0.05 M Tris-HCl (pH 7.6). Residual tetrahydrofuran was removed from
the solution by gentle flushing with nitrogen [29]. The DPH working
solution was stored in the dark at 4 °C until use but for no longer than
2 weeks.
2.2. Determination of MIC and MBC
To identify the minimal inhibitory concentration (MIC) of farnesol,
overnight bacterial cultures were diluted and inoculated at a con-
centration of 104 CFU/ml in 100 μl of TSB on a 96-well plate. Bacteria
were grown in the presence of two-fold dilutions of FRN at 37 °C with
shaking in the dark. After 24 h, the MIC was determined as the lowest
concentration that caused growth inhibition (clear broth). To indicate
minimal bactericidal concentration (MBC), the whole content of wells
including MIC and those with higher FRN concentrations were spread
onto 2% agar plates. MBC was determined as the lowest concentration
resulting in the total eradication of bacteria (no colonies after 24 h).
Parallel assays to determine the MIC and MBC of farnesol were con-
ducted in the presence of a photosensitizer (20 μM). In case of MIC and
MBC determination in the presence of TMPyP, the photosensitizer was
added along with FRN. Experiments were performed with three in-
dependent biological experiments. In further experiments, a sub-
inhibitory concentration of FRN equaled ½ MIC.
2.3. PDI
Bacterial strains were cultured for 24 h, with or without sub-
inhibitory concentrations of FRN, and then diluted with fresh broth to a
density of 0.4 McFarland units (107 CFU/ml). A total of 110 μl of each
culture was loaded into a 96-well plate and incubated in the dark at
37 °C for 30 min, either with or without the addition of one of the
following PSs: TMPyP, phenothiazine toluidine blue O (TBO), or pro-
toporphyrin IX (PPIX) at 20 μM or zinc phthalocyanine (ZnPC) at 5 nM.
In our experimental setup the cells were either cultured (pre-incuba-
tion) in a presence of farnesol for 24 h, and subjected to PS and light, or
cells were cultured standard, and farnesol was added along with PS (co-
incubation) for 30 min prior irradiation. All the necessary controls were
carried out accordingly including: cells treated with PS and light, cells
treated with light alone, cells cultured in the presence of farnesol for
24 h and then treated with light (no PS added), cells treated with far-
nesol shortly prior to light (no PS added). Before light treatments, 10 μl
aliquots were collected for CFU assessment and served as dark controls.
Samples were irradiated with light doses ranging from 10 to 30 J/cm2.
For the irradiation procedure, LED lamps, emitting incoherent red light
(λmax 632 nm) (EMD Technology, Poland), designed and produced by
the Laboratory of Molecular Diagnostics, were used [30]. The technical
parameters were set as follows: output power of 23.4 mW/cm2 and
energy dose of 10–30 J/cm2. Thus, 7 min 7 s were required for every
10 J/cm2 emitted. After irradiation with each 10 J/cm2, 10 μl of the
samples were collected to perform ten-fold serial dilutions in PBS
buffer, ranging from 10−1 to 10−4. Aliquots of each dilution were
streaked onto agar plates. After overnight incubation at 37 °C, the co-
lonies that formed were counted to assess bacterial viability. All ex-
periments were performed with three independent biological experi-
ments.
2.4. Accumulation of TMPyP
Bacterial strains were cultured for 24 h, with or without sub-
inhibitory concentrations of FRN, and then diluted in PBS buffer to a
density of 0.4 McFarland units. A total of 800 μl of bacterial suspension
containing 5 × 107 CFU was centrifuged at 5000 ×g for 10 min, sus-
pended in 800 μl of fresh PBS with the addition of 20 μM TMPyP (giving
0.32 pmol per 103 CFU), with or without FRN. Bacteria were incubated
in the dark at 37 °C for 30 min (same as in the PDI procedure) and then
centrifuged. After a 1:10 dilution in PBS, the absorbance of super-
natants was measured at 422 nm using a SPECORD® PLUS UV/Vis
spectrophotometer (Analytik Jena, Germany). The concentration of
TMPyP remaining in the supernatant after incubation with bacterial
cells was calculated based on a molar extinction coefficient,
ε422 = 2.26 × 105 M−1 cm−1 [31]. Experiments were performed with
three independent biological experiments.
2.5. Analysis of TMPyP Absorption Spectra
TMPyP (5 μM) in 1 ml of distilled water was titrated with increasing
concentrations of farnesol and incubated in the dark at 37 °C for
30 min. Alternatively, samples were irradiated in a 24-well plate with
red light at a dose of 20 J/cm2. Absorption spectra were recorded using
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a UV–Vis Beckman DU-640 spectrophotometer (Beckman Coulter, USA)
in the range of 360–750 nm. Absorption spectra were normalized to
TMPyP concentration and presented as molar absorption. Samples were
prepared and measured in three independent experiments.
2.6. Analysis of TMPyP Fluorescence Spectra
TMPyP (5 μM) in 200 μl of distilled water was titrated with in-
creasing concentrations of farnesol and incubated in the dark at 37 °C
for 30 min in a 96-well black plate. Fluorescence spectra were recorded
employing an EnVision® Multilabel Plate Reader (Perkin-Elmer, USA)
using two excitation wavelengths in Q band and Soret region, respec-
tively at 518 nm and 420 nm, and an emission range of 600–800 nm at
2 nm intervals. Concentration of TMPyP was 5 μM in samples excited at
518 nm and 0.05 μM in those excited at 420 nm. Samples were pre-
pared and measured in three independent experiments.
2.7. Oxygen Species Formation
2.7.1. Time-resolved spectroscopic detection of 1O2
The effect of farnesol on the photogeneration of singlet oxygen by
TMPyP was analyzed by directly detecting singlet oxygen phosphores-
cence according to the method described elsewhere [32]. In brief, 1 ml
of a phosphate-buffered (pH 7.4, 10 mM) D2O solution of TMPyP in a 1-
cm optical path quartz fluorescence cuvette (QA- 1000; Hellma, Mull-
heim, Germany) was excited with 440 nm light pulses generated by an
integrated nanosecond DSS Nd:YAG laser system equipped with a
narrow bandwidth optical parametric oscillator (NT242-1 k-SH/SFG;
Ekspla, Vilnius, Lithuania). To adjust the photoexcitation energy to
values appropriate for singlet oxygen phosphorescence measurements,
the laser beam was attenuated with four pieces of wire mesh (light
transmission of each wire mesh ~42%). An FRN solution in ethanol was
added to the sample in aliquots of 3.5 μl. The near-infrared lumines-
cence was measured perpendicularly to the excitation beam in a
photon-counting mode using a thermoelectric cooled NIR PMT module
(H10330–45, Hamamatsu, Japan) equipped with a 1100 nm cutoff filter
and additional dichroic narrow-band filter NBP, selectable from the
spectral region range of 1150–1355 nm (NDC Infrared Engineering Ltd.,
Bates Road, Maldon, Essex, UK). Data were collected using a computer-
mounted PCI-board multichannel scaler (NanoHarp 250; PicoQuant
GmbH, Berlin, Germany). Data analysis, including first-order lumines-
cence decay fitted by the Levenberg–Marquardt algorithm, was per-
formed by custom-written software. The acquisition time of obtaining
singlet oxygen phosphorescence signals was 20 s.
2.7.2. Detection of oxygen radicals
EPR spin trapping was employed using 100 mM DMPO as a spin
trap. For detection of superoxide anion samples containing TMPyP or
TMPyP with the addition of 35, 70, 105 μM FRN in 90% DMSO were
irradiated in EPR quartz flat cells in the resonant cavity with 402 to
508 nm (10 mW/cm2) light derived from a 300 W high pressure com-
pact arc xenon lamp (Cermax, PE300CE-13FM/Module300W; Perkin-
Elmer Optoelectronics, GmbH, Wiesbaden, Germany) equipped with a
water filter, heat-reflecting hot mirror, cutoff filter that blocked light
below 390 nm and blue additive dichroic filter 505FD64–25 (Andover
Corporation, Salem, NC, USA). To detect hydroxyl radicals that could
be photogenerated by TMPyP in the presence of the selected con-
centration of farnesol, the same experimental procedure was employed
as above, except distilled water was used instead DMSO. EPR samples
were run using a microwave power of 10.6 mW, modulation amplitude
of 0.05 mT, center field of 339.0 mT, scan width of 8 mT, and scan time
of 21 s. EPR measurements were performed using a Bruker EMX-AA
EPR spectrometer (Bruker BioSpin, Rheinstetten, Germany).
2.8. Carotenoid Extraction
Bacterial strains were cultured for 24 h, with or without sub-
inhibitory concentrations of FRN, and diluted in fresh broth to
OD600 = 2. Based on a modified protocol of Lipovsky et al. [33], five-
milliliter suspensions were centrifuged at 4000 ×g for 10 min at 4 °C,
and the cell pellets were washed with distilled water, thoroughly sus-
pended in 1.5 ml of 99% methanol (POCH, Poland) and gently agitated
for 2 h in the dark until bleached. The samples were centrifuged at
10,000 ×g at 4 °C for 15 min, and the absorbance of the supernatants
was measured at 450 nm using a Novaspec II spectrophotometer
(Pharmacia Biotech, USA). Experiments were performed with three
independent biological experiments.
2.9. Bacterial Membrane Fluidity Assay
Bacteria were cultured for 24 h, with or without subinhibitory
concentrations of FRN. Bacterial suspensions were prepared at a density
of 4.5 McFarland units (108 CFU/ml) in TSB medium. Bacteria that
were not cultured in the presence of FRN were incubated for 30 min
with subinhibitory concentrations of FRN. Samples without FRN served
as controls. Temperature-dependent membrane fluidity was quantified
according to modified protocols of Bayer and Voss [29,34], as described
previously [26]. Suspensions were pelleted by centrifugation (5000 ×g,
15 min) and then suspended in 500 μl of digestion buffer (20% [w/v]
sucrose, 0.05 Tris-HCl [pH 7.6], 0.145 M NaCl). The bacterial cell wall
was then digested with 0.8 U of lysostaphin (A&A Biotechnology, Po-
land) in the presence of 3 U of DNase I (EURx, Poland) for 1 h at 37 °C
[29]. Protoplasts were collected by centrifugation (9000 ×g, 15 min)
and suspended in 200 μl of fresh digestion buffer. For DPH labeling,
protoplasts suspended in digestion buffer were mixed with DPH solu-
tion in a 1:1 ratio to obtain a 2 μM final concentration and incubated in
the dark at 30 °C for 45 min. Spectrofluorometer FP-8500 (JASCO, USA)
coupled with Spectra Manager™ software was used for fluorescence
intensity and anisotropy (r) measurements. Analysis was carried out in
a labeled cell suspension volume of 300 μl, agitated at 200 rpm, in a
temperature gradient ranging from 20 to 40 °C (rate of increase, 1 °C
per 1 min). A blank measurement was recorded using the unlabeled cell
suspension of each strain separately, at a single initial point, as no
significant changes in background fluorescence intensity of unlabeled
protoplasts were observed during the whole measurement. The fol-
lowing parameters were used: a vertically polarized excitation wave-
length of 360 nm (bandwidth 5 nm) and an emission wavelength of
426 nm (bandwidth 10 nm) analyzed through a rotating polarizer.
Signals were measured for 2 s at each 2.5 °C interval. A G factor of
1.2017 was used. Experiments were performed with two to three in-
dependent biological experiments.
3. Results
3.1. Farnesol Potentiates the Bactericidal Activity of TMPyP Upon Red
Light Irradiation
FRN, as an antimicrobial agent, shows bactericidal activity at cer-
tain concentration. To determine the appropriate dosage for a sub-
inhibitory treatment, the MIC and MBC of FRN were determined.
Depending on the S. aureus strain, the FRN MIC was in the range of
70–140 μM (Table 1). The concentrations equal to ½ MIC was used in
further experiments (70 μM for SH1000 and 35 μM for RN6390). For
antimicrobial PDI, we used the following four types of red light-ab-
sorbing PSs at concentrations selected in previous experiments in our
laboratory [26]: TBO, PPIX, cationic meso-substituted porphyrin
TMPyP and ZnPC. Strains SH1000 and RN6390, derived from the same
reference strain 8325 [35], differ mainly in the status of the rsbU gene,
which implies various phenotypic features crucial to PDI sensitivity.
Therefore, both strains respond differently to PSs, such as PPIX or ZnPC
M. Kossakowska-Zwierucho, et al. Journal of Photochemistry & Photobiology, B: Biology 206 (2020) 111863
3
[26]. Antibacterial PDI in the presence of FRN revealed additional in-
teresting differences in the effectivity of the PSs (Fig. 1). Addition of
FRN sensitized both strains to TBO and TMPyP, leading to a pro-
nounced bactericidal effect of the latter PS. Maximal viability reduction
in the case of TBO reached 3 log10 units in strain RN6390; however, in
the case of TMPyP, the reduction in viable bacterial count exceeded 5
log10 units at the light dose of 20 J/cm2 (values higher than 3 log10
units, thus 99.9% reduction, indicate a bactericidal effect [36]). Sur-
prisingly, the bactericidal effect of ZnPC towards RN6390 (> 5 log10
units of viability reduction) was completely abolished in the presence of
FRN. No significant change in the response of both strains to PPIX was
noted. We applied two various approaches to study potentiation of PDI
by FRN: in the first one cells were cultured for 24 h in the presence of
FRN and then subjected to PDI, those cells were called pre-incubated. In
the second approach, FRN and PS were added to standard grown cells
and co-incubated for only 30 min prior to light exposure. Differences in
the efficacy of PDI were observed after co-incubation of cells with PS
and FRN prior to irradiation (thus when FRN was present at a final
concentration in the irradiated mixture), but not when the bacteria
were cultured (pre-incubated) with FRN and only then treated with PS
and irradiated. The PSs examined in this study revealed various effi-
cacies in the presence of FRN, with no characteristic pattern related to,
for example, the chemical structure of the PSs, perhaps except for the
fact that TBO and TMPyP are positively charged under the conditions
studied. Our further analysis focused on the combination of FRN and
TMPyP due to the specific potentiation of the bactericidal action.
Without the addition of FRN, the photodynamic activity of red light-
irradiated TMPyP was negligible under the conditions studied. Bacter-
icidal activity was attributed to a combination of both compounds and
light, since no relevant killing of S. aureus was observed after separate
FRN and TMPyP treatment, in the dark or upon irradiation in control
samples (Table 2). The combination of both compounds in the dark did
not lead to bacterial killing, which was also supported by the ob-
servation that the MIC and MBC values of FRN did not depend on the
presence of TMPyP (Table 1). Importantly, the observed bactericidal
effect was achieved using red light, which was previously shown to be
ineffective in the TMPyP-mediated photoinactivation of S. aureus [26].
3.2. Farnesol Does Not Affect the Spectral Properties of TMPyP
Since FRN demonstrated simultaneous action with TMPyP towards
S. aureus, we examined whether FRN alters the spectral properties of
TMPyP. Using this approach, changes in the concentration or electronic
structure of TMPyP in a mixture can be inferred from the analysis of
absorption spectra. TMPyP (at a concentration of 5 μM, which enabled
unbiased absorbance recording) was titrated with increasing con-
centrations of FRN: the concentration of FRN was lower, equal and
higher than that of the analyte. Samples were incubated and kept in the
dark or irradiated, reflecting the conditions applied during the PDI
experiment to observe the possible formation of chemical inter-
mediates. Full-range absorption spectra of TMPyP were recorded and
normalized to concentration, revealing no changes in the intensity or
the position of the Sorret region and Q bands (Fig. 2A). This finding
shows that the potentiation of TMPyP activity is not attributed to a
change in absorance in the range covering the emission spectrum of the
applied light source. In a similar experiment, we analyzed the
fluorescence of TMPyP in the presence of FRN (Fig. 2B). No change in
emission spectra was recorded upon incubation with increasing con-
centrations of FRN. The lack of alteration in TMPyP spectral properties
suggests that TMPyP does not react with FRN under the applied ex-
perimental conditions and that no interaction that affects the spectral
properties of TMPyP occurs.
3.3. Farnesol Does Not Affect Reactive Oxygen Species Formation by
TMPyP
Without altering the structure of the PS, FRN could potentiate
TMPyP photodynamic action by increasing the efficiency of the PS to
generate reactive oxygen species. To verify this hypothesis, analyses of
singlet oxygen and superoxide anion formation were conducted by
means of time-resolved detection of 1O2 phosphorescence and EPR-spin
trapping of oxygen radicals, respectively (Fig. 3). As seen in the ob-
tained results, FRN neither significantly modified the TMPyP-mediated
formation and decay of singlet oxygen nor the generation of superoxide
anions. In principle, farnesol could also potentiate the photodynamic
efficiency of TMPyP via the formation of a cytotoxic product - a result of
the farnesol interaction with singlet oxygen or/and superoxide anion.
The results shown in Fig. 3 exclude this possibility. It is evident that
even at the highest concentration of FRN used, the lifetime of singlet
oxygen was practically unchanged, indicating a very inefficient inter-
action of farnesol with this reactive oxygen species. While the EPR spin
trapping data may indicate a small inhibition of the formation of the
DMPO-OOH spin adduct, in the presence of highest concentration of
farnesol tested by us, the effect is rather inconsistent with the dramatic
potentiation of the bactericidal PDI described above. Importantly, no
other spin adducts developed in the presence of even the highest con-
centration of FRN. To test if farnesol affected possible photoformation
of hydroxyl radicals, spin trapping experiments were carried out using
distilled water as the solvent. Under the same experimental conditions
as those employed for spin trapping of superoxide anion, only a residual
signal of the DMPO-OH spin adduct was detected with little modulatory
effect of farnesol (data not shown). Considering that at the very high
concentration of DMPO used, most of hydroxyl radicals would have
been spin-trapped the data clearly show that hydroxyl radicals are not
involved in the observed potentiation of bacterial PDI by FRN. There-
fore, the results indicate that the potentiation of TMPyP bactericidal
action induced by FRN is not related to the modified formation and
decay of reactive oxygen species photogenerated by TMPyP.
3.4. Farnesol Does Not Increase TMPyP Accumulation in S. aureus
Since the combined activity of farnesol and TMPyP cannot be at-
tributed to the potentiation of the photodynamic properties of a PS, a
possible effect on its accumulation in bacterial cells was analyzed. It has
been documented in the literature that FRN can act as an adjuvant for
various antibacterial agents, such as antibiotics. The major part of this
synergistic action is due to the disruption of the bacterial membrane,
enabling the increased penetration of the antibacterial agent [20]. To
assess whether FRN facilitates the accumulation of TMPyP in bacterial
cells, the uptake of a PS in aqueous solution was measured under
conditions reflecting those applied during the PDI experiment. A simple
spectrophotometric method was applied to directly calculate the
amount of the PS that accumulated in bacterial cells or adsorbed on a
cell surface, causing a decrease in TMPyP concentration in aqueous
solution. The analysis, including bacteria preincubated (grown) in the
presence of FRN and those coincubated with FRN and TMPyP, showed
increased PS uptake in strain SH1000 after preincubation with FRN
(Fig. 4). This result can be explained by a change in staphyloxanthin
content, which would result in the altered composition of the bacterial
membrane. However, after a short coincubation of bacteria with FRN
and TMPyP, the condition with the maximal bactericidal effect, an in-
crease in PS uptake was not observed. This finding showed that FRN
Table 1
MIC and MBC of farnesol. Concentrations were determined in three replicates in
TSB broth and 20 μM TMPyP was added.
MIC [μM] MBC [μM]
FRN FRN + TMPyP FRN FRN + TMPyP
SH1000 70–140 70–140 140 140
RN6390 70 70 70 70
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Fig. 1. Phototoxic effect of various PSs and red light against S. aureus in the presence of farnesol. Graphs show the S. aureus strains SH1000 (A) and RN6390 (B). The
concentrations of farnesol used were 70 μM for SH1000, and 35 μM for RN6390. . Viability counts are the mean values of three independent biological experiments.
Error bars represent the standard error calculated by dividing the standard deviation by the square root of the number of replicates. Asterisks indicate significance at
p < .015 according to Student's t-test, compared to light controls (0 μM TMPyP, 0 μM FRN). The studied PSs were used at the following concentrations: TMPyP
(5,10,15,20-tetrakis(1-methylpyridinium-4-yl)porphyrin tetratosylate), TBO (phenothiazine toluidine blue O), PPIX (protoporphyrin IX) at 20 μM, ZnPC (zinc
phthalocyanine) at 5 nM. Ctrl – cells exposed to light only; FRN pre-incub. – cells cultured with FRN for 24 h; FRN incub. - cells incubated with FRN for 30 min; PS –
cells treated with respective PS; PS-FRN pre-incub. - cells cultured with FRN for 24 h, incubated with PS and then irradiated; PS-FRN co-incub. - cells incubated with
PS and FRN for 30 min. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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does not facilitate the penetration of a PS through bacterial envelopes
and that some other mechanisms are involved.
3.5. Effect of Farnesol on Bacterial Membrane: Staphyloxanthin Content
and Membrane Fluidity
S. aureus sensitivity to PDI, aside from photodynamic properties and
the accumulation of a compound, can depend on various bacterial
phenotypic features, such as staphyloxanthin content and the degree of
bacterial membrane fluidity. Farnesol is a known inhibitor of the sta-
phyloxanthin synthesis pathway in S. aureus [37]. This inhibition was
confirmed in strain SH1000 after 24 h of growth in the presence of FRN,
which lowered the level of carotenoids to the levels observed in the
nonpigmented strain RN6390 (Fig. 5). However, taking into account
that the best bactericidal effect was achieved after a relatively short
treatment, in which bacterial bleaching could not yet be observed, the
inhibition of staphyloxanthin synthesis does not seem to be crucial for
this phenomenon. A combined bactericidal effect was observed in both
strains SH1000 and RN6390 independent of their overall carotenoid
content.
Farnesol can alter the structure of the bacterial membrane, which
can be detected by means of its fluidity. DPH, a lipophilic fluorescent
probe used to observe membrane fluidity, preferentially localizes to
hydrophobic (intrinsic) regions of cell membrane phospholipids and
emits polarized light upon excitation. The value of fluorescence aniso-
tropy (r) reflects the degree of a fluorophore's free movement that is
dependent on membrane fluidity. An inverse relationship occurs be-
tween the measured DPH fluorescence anisotropy and membrane
fluidity [38]. Temperature-dependent analysis of strain SH1000 re-
vealed a change in membrane structure after FRN treatment. After
30 min of incubation, an increase in membrane fluidity was observed at
each measurement point. After 24 h of treatment with FRN, the fluidity
was further increased, which is probably connected to the lack of sta-
phyloxanthin in the bacterial membrane (Fig. 6). The analysis of
RN6390 also revealed noticeable changes after FRN treatment; how-
ever, the initial increase in membrane fluidity subsided after 24 h. The
fact that the r values of “bleached” SH1000 did not match those of
nonpigmented RN6390 suggests that other factors exist that regulate
overall membrane fluidity. Nevertheless, increased fluidity after short
FRN treatment suggests a higher degree of structural disorder and can
to some extent contribute to the bactericidal effect observed in both
strains.
4. Discussion
The present research is the first report describing the use of FRN as
an adjuvant in antibacterial PDI. The effect of FRN on PDI efficacy is not
common to various types of red light-absorbing PSs. The compounds
used in our study included a phenothiazine representative, TBO, and
three PSs based on a cyclic tetrapyrrole structure: cationic meso-sub-
stituted porphyrin TMPyP, PPIX and zinc phthalocyanine. A strong
potentiation of bactericidal action in the presence of FRN was observed
only for TMPyP and for a much lesser extent for TBO (Fig. 1). A specific
action of FRN and TMPyP occurred shortly after simultaneous incuba-
tion and only in the presence of light. With respect to the fact that PDI,
as well as farnesol, acts in bacterial cells in a multidirectional manner, a
precise mechanism of this specific action is still not fully understood. To
explain this unique potentiation of TMPyP-based PDI, we applied a
classical approach to analyze the photodynamic properties of TMPyP in
combination with FRN. Surprisingly, none of the basic characteristics,
including spectral properties, reactive oxygen species formation and PS
uptake, provided an explanation for the observed phenomenon. To-
gether with a very diverse effect obtained for other PSs (including
abolishing ZnPC bactericidal action), we hypothesize that farnesol af-
fects specific molecular targets crucial for S. aureus sensitivity to
TMPyP-based PDI. Bacterial membrane proteins and lipids are con-
sidered the main molecules affected by PDI [36,39] and specific phos-
pholipids have been reported to be modified in Staphylococcus warneri
in the presence of cationic porphyrin derivative [40]. Specifically, in
the case of TMPyP particular targets have been previously identified in
the photoinactivation of nonenveloped RNA viruses [41]. A unique
potentiation of this compound further suggests that despite the gen-
erally accepted universality of the PDI method, PSs can act through
specific molecular mechanisms.
Even though the molecular background of the combined FRN and
TMPyP photodynamic action remains unclear, such an outcome is very
promising in the context of possible in vivo applications due to the
possible use of red light. Cationic meso-substituted porphyrin deriva-
tives, such as TMPyP, are generally referred to as potent singlet oxygen
producers [23]. The cationic character of these compounds promotes
binding to negatively charged bacterial cell surfaces. However, the
characteristic structure of these derivatives implies their decreased
ability to absorb in a range of red light (molar absorption coefficient
determined for Q bands is relatively low compared to unsubstituted
porphyrins) [2]. Accordingly, in this phenomenon, meso-substituted
porphyrins are often activated with blue or broad-spectrum white light
[40,42,43]. As we showed, TMPyP alone irradiated with an applied
Table 2
Phototoxic effect of 20 μM TMPyP, farnesol and red light on S. aureus cells.






FRN pre-incub. FRN co-incub.
SH1000 0 0.1 ± 0.06 0.0 ± 0.0 0.08 ± 0.05 0.0 ± 0.0 0.20 ± 0.05
10 0.14 ± 0.05 −0.09 ± 0.01 0.83 ± 0.31 0.16 ± 0.06 2.6 ± 0.21
20 0.27 ± 0.16 0.06 ± 0.06 1.72 ± 0.55 0.02 ± 0.03 5.1 ± 0.45
30 1.13 ± 0.28 −0.1 ± 0.1 3.04 ± 0.84 0.07 ± 0.04 5.62 ± 0.06
RN6390 0 0.01 ± 0.03 0.0 ± 0.0 0.14 ± 0.08 0.0 ± 0.0 −0.01 ± 0.02
10 0.17 ± 0.07 0.02 ± 0.03 0.19 ± 0.12 0.06 ± 0.09 2.64 ± 0.46
20 0.57 ± 0.32 0.0 ± 0.04 0.22 ± 0.01 0.11 ± 0.04 5.78 ± 0.11
30 1.17 ± 0.15 0.01 ± 0.02 1.67 ± 0.46 0.26 ± 0.19 5.89 ± 0.05
The values were calculated by subtracting log10 CFU/ml of treated samples from those of untreated controls (0 J/cm2; 0 μM TMPyP, 0 μM FRN). Bold values indicate
a bactericidal effect (> 3 log10 reduction units). Underlined values indicate significance at p < .01 according to Student's t-test, compared to light controls (0 μM
TMPyP, 0 μM farnesol). Results are presented as mean values of three experiments with a standard error calculated by dividing standard deviation per square root of
the number of replicates. FRN pre-incub. – bacteria cultured with FRN for 24 h; FRN incub. – bacteria incubated with FRN shortly prior to irradiation; FRN co-incub. –
bacteria irradiated with TMPyP and FRN after short incubation with both compounds.
FRN – farnesol; TMPyP - 5,10,15,20-tetrakis(1-methylpyridinium-4-yl)porphyrin tetratosylate.
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light source (λmax 632 nm) remained ineffective at the photodynamic
killing of S. aureus; however, in combination with farnesol and red
light, a pronounced bactericidal effect can be achieved. The observed
phenomenon enables the use of wavelengths that are beneficial for
therapeutic use. Shorter wavelengths can be strongly absorbed by blood
and scattered by biological structures. The more redshifted the visible
light used in PDI is, the more efficient is the tissue penetration [44].
The unclear mechanism of the TMPyP and FRN combined action is
connected to the complex nature of PDI and to the elusive pleiotropic
effect caused by FRN in bacterial cells. The antibacterial activity of
farnesol, as well as its role in the potentiation of antibacterial agents,
has been described in the literature, especially for gram-positive bac-
teria [21,22,45,46]. Its primary mode of action has been attributed to
the disruption of the cell membrane that occurs shortly after exposure,
causing a drastic release of K+ ions without affecting potassium chan-
nels [47,48]. The affinity of FRN for bacterial membranes results from
its hydrophobic nature. It has also been reported that the morphology
of S. aureus cells treated with a high concentration of FRN was similar
to that caused by cell wall-active antibiotics [49]. With respect to this
mode of action, FRN in combination with antibacterials is believed to
facilitate the penetration of compounds and to enhance their bacter-
icidal action at lower concentrations [20–22]. Apart from altering the
structure of the bacterial cell envelope, FRN seems to induce multiple
Fig. 2. Molar absorption and fluorescence spectra of 5 μM TMPyP titrated with
farnesol. A) Molar absorption spectra of 5 μM TMPyP in water. Solid lines in-
dicate samples titrated with increasing concentrations of FRN and incubated for
30 min at 37 °C in the dark. Dashed lines indicate corresponding samples ir-
radiated with red light at a dose of 20 J/cm2 (PDI). B) Fluorescence spectra.
Graphs show fluorescence emission spectra of 5 μM TMPyP in water exited in Q-
band (ex. 518 nm) after titration with increasing concentrations of FRN and
incubation for 30 min at 37 °C in the dark. C) Fluorescence emission spectra of
0.05 μM TMPyP in water excited in Soret region (ex. 420 nm) after titration
with increasing concentrations of FRN and incubation for 30 min at 37 °C in the
dark. A.U. – arbitrary units. Lines present mean values for three independent
measurements. (For interpretation of the references to colour in this figure le-
gend, the reader is referred to the web version of this article.)
Fig. 3. Reactive oxygen species formation in the presence of farnesol. A) Time-
resolved detection of singlet oxygen phosphorescence. Signals were recorded
for 20 μM TMPyP alone and with the addition of increasing concentrations of
farnesol. B) Detection of superoxide anions generated by TMPyP at a 20 μM
concentration. The pattern of superoxide spin amplitude was compared with
the signal generated after the addition of 35 μM farnesol.
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metabolic changes in S. aureus, some of which have been described in
the literature. FRN blocks an initial stage in the staphyloxanthin
synthesis pathway, where, due to its structural analogy to farnesyl
pyrophosphate, it binds the dehydrosqualen synthase CrtM and pre-
vents all further carotenoid compound formation [37]. FRN also com-
petitively inhibits the activity of a staphylococcal lipase [50] and affects
fibrin fiber formation by inhibiting coagulase [49]. Another process
affected by FRN in S. aureus is the recycling of the C55 lipid carrier of
the murein monomer precursor, which leads to the disruption of cell
wall biosynthesis [37]. Moreover, FRN affects the mevalonate pathway
by inhibiting staphylococcal HMG-CoA reductase, which leads to
growth inhibition [51]. It is also an agent known to prevent biofilm
formation in S. aureus and coagulase-negative staphylococci
[20,46,52]. In another microorganism, C. albicans, farnesol acts as a
quorum-sensing molecule, where it prevents the transition from yeast to
hyphal growth and compromises biofilm formation [19]. In S. aureus,
however, it is doubtful that the antimicrobial effect of FRN depends on
this quorum-sensing mechanism, as this crosstalk in staphylococci in-
volves mainly autoinducing peptides and the accessory gene regulator
system [20].
As shown in this report, FRN also enhanced the PDI of S. aureus.
Several attempts have been undertaken to explain the observed po-
tentiation of red light-activated TMPyP by this multifunctional sesqui-
terpenoid. First, we investigated the possibility that farnesol interacts
with TMPyP and forms a toxic intermediate or improves the action of
the PS by modulating the absorption capability. However, the anti-
bacterial activity of farnesol was not increased by TMPyP as evidenced
by MIC values and dark toxicity in PDI experiments (Tables 1 and 2).
Additionally, no changes in TMPyP absorption and fluorescence spectra
in the presence of FRN were observed, even in irradiated samples
(Fig. 2). Since oxidative stress is an inherent element of PDI, we also
analyzed reactive oxygen species generation in the presence of FRN.
The potential formation of ROS in S. aureus upon FRN treatment has
been analyzed and described in the literature. Inoue et al. reported that
farnesol does not induce the formation of ROS in planktonic S. aureus
culture [48]. On the other hand, in the case of S. aureus biofilm, the
FRN produced by C. albicans promoted intracellular ROS accumulation,
as described elsewhere [53]. It was also shown that FRN inhibited
oxidation-reduction reactions in S. aureus [20] and S. epidermidis [46].
However, the experiments conducted in the present work revealed no
influence of FRN on the ROS generation induced by TMPyP (Fig. 3).
This confirms that the mechanism of the observed phenomenon does
not depend on the modulation of TMPyP photodynamic properties. We
should also take into consideration that ROS generated by excited
TMPyP during PDI can affect farnesol molecules resulting in formation
of a toxic product. However, since all analyzed photosensitizers are
generally referred to as potent singlet oxygen producers, the expected
bactericidal effect in a presence of farnesol would be observed for all
used compounds. The observed phenomenon also cannot be explained
by the amount of PS accumulated by S. aureus under the analyzed
conditions (Fig. 4). Incubation with farnesol did not enhance TMPyP
uptake, which suggests no increased penetration of the PS in the dark. It
is worth mentioning, however, that the applied method quantitatively
measured PS uptake, but it did not determine the location of the
compound inside a bacterial cell. In general, TMPyP accumulation in
the cytosol or cell wall of S. aureus is considered minor during in-
cubation in the dark, and TMPyP only enters following cell wall damage
[54]. Once in the cell, TMPyP has the potential to bind DNA [55];
however, high intracellular concentrations of this PS are needed to
evoke DNA damage in bacteria [56].
It is worth noting that the reported effect is independent of the
genetic background involving rsbU gene status, which affects the
synthesis capability of staphyloxanthin. Under basic PDI conditions
(without FRN), the strains SH1000 and RN6390 responded differently
to other tetrapyrrole-based PSs, namely, PPIX and ZnPC (Fig. 1). The
PDI experiments revealed that the bactericidal effect of combined
TMPyP, farnesol and red light towards both strains was equal and oc-
curred shortly after FRN addition (Table 2). Bacterial killing was much
more prominent under these conditions than under conditions in which
PDI was applied to cells preincubated (cultured for 24 h) with FRN. This
outcome somehow negates the contribution of the metabolism altera-
tion induced by FRN in S. aureus and suggests a more rapid reaction.
During growth in the presence of FRN, the staphyloxanthin synthesis
pathway is inhibited at a preliminary stage, resulting in the lack of the
whole pool of carotenoids (Fig. 5). Although carotenoid content was
previously described as a significant factor of PDI outcome in S. aureus
[26], it does not significantly affect response to red light-activated
TMPyP. In another aspect, FRN induces the reorganization of mem-
brane structure, which is reflected by the increase in its fluidity. This
process is indirectly connected to the lack of staphyloxanthin, which
plays a role in maintaining bacterial membrane rigidity similar to that
of cholesterol in mammalian cells [57]. An increase in membrane
fluidity upon incubation with FRN was observed in both strains SH1000
and RN6390 (Fig. 6). In the former strain, the effect was dependent on
the incubation time with farnesol. For strain RN6390, this trend was not
clear; however, in the presence of FRN, membrane fluidity was
Fig. 4. Accumulation of TMPyP in S. aureus. Bacterial cells were incubated with
20 μM TMPyP. The concentration of TMPyP remaining in PBS after incubation
was calculated, resulting in the fmol of a PS accumulated per 1000 cells. Boxes
represent the mean values of three biological replicates for samples without
FRN, with FRN at subinhibitory concentration (70 μM for SH1000 and 35 μM
for RN6390) added 30 min before measurement and samples preincubated with
FRN for 24 h. Error bars represent the standard error calculated by dividing
standard deviation by the square root of the number of replicates.
Fig. 5. Carotenoid content after treatment with farnesol. Bacteria were grown
at subinhibitory concentrations of FRN (70 μM for SH1000 and 35 μM for
RN6390) for 24 h, and the absorbance of methanol extracts was measured.
Boxes represent the mean values of three biological replicates. Error bars re-
present the standard error calculated by dividing the standard deviation by the
square root of the number of replicates.
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increased. This outcome is probably connected to a natural lack of
staphyloxanthin in this strain and suggests that changes in membrane
structure occur shortly after FRN addition regardless of staphyloxanthin
level. As reported by Inoue et al., an increase in membrane fluidity was
observed mainly in the superficial layer only after 3 min of exposure to
high FRN concentrations [48]. It is worth mentioning, however, that
the concentrations of FRN used in our study were lower than in the
concentrations used in most previous reports.
Our results suggest that the potentiation of red light-activated
TMPyP is specific, rapid and does not influence PS photodynamic
properties by means of spectral changes and ROS generation. The
identification of the mechanisms and molecular targets involved in the
observed phenomenon requires further investigation. The combined
action of farnesol and TMPyP opens a new path in searching for ad-
juvants in antibacterial PDI.
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